Dendritic cells in atherosclerosis: Evidence in mice and humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 4, 2015, Pages 763-770

  Zernecke, Alma ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

atherosclerosis; dendritc cells; humans; immune system; inflammation; leukocytes; mice

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LIPID;

ADVENTITIA; ANTIGEN PRESENTING CELL; ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; HOMEOSTASIS; HUMAN; LIPID STORAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; ADOPTIVE TRANSFER; ANIMAL; ARTERY; ATHEROSCLEROTIC PLAQUE; CELL MOTION; CLASSIFICATION; FOAM CELL; IMMUNOLOGY; LIPID METABOLISM; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CELL MOVEMENT; DENDRITIC CELLS; FOAM CELLS; HUMANS; LIPID METABOLISM; LYMPHOCYTE ACTIVATION; MICE; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84930252551     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303566     Document Type: Article

References (54)

1. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204-212. doi: 10.1038/ni.2001.
2. Manthey HD, Zernecke A. Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb Haemost. 2011;106:772-778. doi: 10.1160/TH11-05-0296.
3. Satpathy AT, KC W, Albring JC, Edelson BT, Kretzer NM, Bhattacharya D, Murphy TL, Murphy KM. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med. 2012;209:1135-1152. doi: 10.1084/jem.20120030.
4. Choi JH, Cheong C, Dandamudi DB, Park CG, Rodriguez A, Mehandru S, Velinzon K, Jung IH, Yoo JY, Oh GT, Steinman RM. Flt3 signalingdependent dendritic cells protect against atherosclerosis. Immunity. 2011;35:819-831. doi: 10.1016/j.immuni.2011.09.014.
5. Koltsova EK, Garcia Z, Chodaczek G, Landau M, McArdle S, Scott SR, von Vietinghoff S, Galkina E, Miller YI, Acton ST, Ley K. Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest. 2012;122:3114-3126. doi: 10.1172/JCI61758.
6. Schraml BU, Reis E Sousa C. Defining dendritic cells. Curr Opin Immunol. 2014;32C:13-20. doi: 10.1016/j.coi.2014.11.001.
7. Miller JC, Brown BD, Shay T, et al; Immunological Genome Consortium. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol. 2012;13:888-899. doi: 10.1038/ni.2370.
8. Dutertre CA, Wang LF, Ginhoux F. Aligning bona fide dendritic cell populations across species. Cell Immunol. 2014;291:3-10. doi: 10.1016/j. cellimm.2014.08.006.
9. Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity. 2014;40:642-656. doi: 10.1016/j.immuni.2014.04.016.
10. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, Yona S. Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny. Nat Rev Immunol. 2014;14:571-578. doi: 10.1038/nri3712.
11. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008;322:1097-1100. doi: 10.1126/science.1164206.
12. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, Locksley R, Holmberg D, Zweier C, den Hollander NS, Kant SG, Holter W, Rauch A, Zhuang Y, Reizis B. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 2008;135:37-48. doi: 10.1016/j.cell.2008.09.016.
13. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med. 2006;203:1273-1282. doi: 10.1084/jem.20052205.
14. Busch M, Westhofen TC, Koch M, Lutz MB, Zernecke A. Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice. PLoS One. 2014;9:e88452. doi: 10.1371/journal.pone.0088452.
15. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol. 2011;31:1506-1516. doi: 10.1161/ATVBAHA.110.221127.
16. Döring Y, Manthey H, Drechsler M, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation. 2012;125:1673-1683. doi: 10.1161/ CIRCULATIONAHA.111.046755.
17. Macritchie N, Grassia G, Sabir SR, Maddaluno M, Welsh P, Sattar N, Ialenti A, Kurowska-Stolarska M, McInnes IB, Brewer JM, Garside P, Maffia P. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2012;32:2569-2579. doi: 10.1161/ATVBAHA.112.251314.
18. Daissormont IT, Christ A, Temmerman L, et al. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res. 2011;109:1387-1395. doi: 10.1161/CIRCRESAHA.111.256529.
19. Sage AP, Murphy D, Maffia P, et al. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation. 2014;130:1363-1373. doi: 10.1161/ CIRCULATIONAHA.114.011090.
20. Yilmaz A, Weber J, Cicha I, Stumpf C, Klein M, Raithel D, Daniel WG, Garlichs CD. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol. 2006;48:70-80. doi: 10.1016/j. jacc.2006.01.078.
21. McGovern N, Chan JK, Ginhoux F. Dendritic cells in humans-from fetus to adult. Int Immunol. 2015;27:65-72. doi: 10.1093/intimm/dxu091.
22. Shi H, Ge J, Fang W, Yao K, Sun A, Huang R, Jia Q, Wang K, Zou Y, Cao X. Peripheral-blood dendritic cells in men with coronary heart disease. Am J Cardiol. 2007;100:593-597. doi: 10.1016/j.amjcard.2007.03.067.
23. Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007;102:123-132. doi: 10.1007/ s00395-006-0636-x.
24. Wen J, Wen Y, Zhiliang L, Lingling C, Longxing C, Ming W, Qiang F. A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: A relation to the severity and extent of coronary artery lesions? Heart Vessels. 2013;28:135-142. doi: 10.1007/ s00380-011-0218-1.
25. Van Vré EA, Hoymans VY, Bult H, Lenjou M, Van Bockstaele DR, Vrints CJ, Bosmans JM. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron Artery Dis. 2006;17:243-248.
26. Yilmaz A, Schaller T, Cicha I, Altendorf R, Stumpf C, Klinghammer L, Ludwig J, Daniel WG, Garlichs CD. Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease. Clin Sci (Lond). 2009;116:353-363. doi: 10.1042/CS20080392.
27. Van Vré EA, Van Brussel I, de Beeck KO, Hoymans VY, Vrints CJ, Bult H, Bosmans JM. Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Coron Artery Dis. 2010;21:87-96. doi: 10.1097/MCA.0b013e3283368c0e.
28. Van Brussel I, Van Vré EA, De Meyer GR, Vrints CJ, Bosmans JM, Bult H. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/ BDCA-2 in coronary artery disease upon activation in whole blood. J Immunol Methods. 2010;362:168-175. doi: 10.1016/j.jim.2010.09.031.
29. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, Anger T, Amann K, Probst T, Ludwig J, Daniel WG, Garlichs CD. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis. 2004;176:101-110. doi: 10.1016/j. atherosclerosis.2004.04.027.
30. Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation. 2006;114:2482-2489. doi: 10.1161/CIRCULATIONAHA.106.642801.
31. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation. 2007;116:2043-2052. doi: 10.1161/ CIRCULATIONAHA.107.697789.
32. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, Romani N, Wick G. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol. 2001;21:503-508.
33. Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, Weih F, Weber C, Gerdes N, Habenicht AJ. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res. 2014;114:1772-1787. doi: 10.1161/ CIRCRESAHA.114.301137.
34. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205. doi: 10.1172/JCI29950.
35. Liu P, Yu YR, Spencer JA, Johnson AE, Vallanat CT, Fong AM, Patterson C, Patel DD. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol. 2008;28:243-250. doi: 10.1161/ATVBAHA.107.158675.
36. Zhu SN, Chen M, Jongstra-Bilen J, Cybulsky MI. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J Exp Med. 2009;206:2141-2149. doi: 10.1084/jem.20090866.
37. Van Vré EA, Van Brussel I, Bosmans JM, Vrints CJ, Bult H. Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques. Mediators Inflamm. 2011;2011:941396. doi: 10.1155/2011/941396.
38. Van Brussel I, Van Vré EA, De Meyer GR, Vrints CJ, Bosmans JM, Bult H. Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clin Sci (Lond). 2011;120:415-426. doi: 10.1042/CS20100440.
39. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoEdeficient mice. Proc Natl Acad Sci U S A. 2006;103:3781-3786. doi: 10.1073/pnas.0511043103.
40. Zernecke A, Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014;34:742-750. doi: 10.1161/ ATVBAHA.113.301655.
41. Angeli V, Llodrá J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity. 2004;21:561-574. doi: 10.1016/j.immuni.2004.09.003.
42. Paulson KE, Zhu SN, Chen M, Nurmohamed S, Jongstra-Bilen J, Cybulsky MI. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res. 2010;106:383-390. doi: 10.1161/ CIRCRESAHA.109.210781.
43. Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Pirault J, Deswaerte V, Ginhoux F, Miller ER, Witztum JL, Chapman MJ, Lesnik P. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation. 2009;119:2367-2375. doi: 10.1161/ CIRCULATIONAHA.108.807537.
44. Stoneman V, Braganza D, Figg N, Mercer J, Lang R, Goddard M, Bennett M. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res. 2007;100:884-893. doi: 10.1161/01. RES.0000260802.75766.00.
45. Choi JH, Do Y, Cheong C, Koh H, Boscardin SB, Oh YS, Bozzacco L, Trumpfheller C, Park CG, Steinman RM. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med. 2009;206:497-505. doi: 10.1084/jem.20082129.
46. Weber C, Meiler S, Döring Y, et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest. 2011;121:2898-2910. doi: 10.1172/JCI44925.
47. Sun J, Hartvigsen K, Chou MY, Zhang Y, Sukhova GK, Zhang J, Lopez-Ilasaca fM, Diehl CJ, Yakov N, Harats D, George J, Witztum JL, Libby P, Ploegh H, Shi GP. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation. 2010;122:808-820. doi: 10.1161/CIRCULATIONAHA.109.891887.
48. Lievens D, Habets KL, Robertson AK, et al. Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J. 2013;34:3717-3727. doi: 10.1093/eurheartj/ehs106.
49. Subramanian M, Thorp E, Hansson GK, Tabas I. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest. 2013;123:179-188. doi: 10.1172/JCI64617.
50. Han SF, Liu P, Zhang W, Bu L, Shen M, Li H, Fan YH, Cheng K, Cheng HX, Li CX, Jia GL. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol. 2007;124:90-97. doi: 10.1016/j.clim.2007.03.546.
51. Ye Y, Yang X, Zhao X, Chen L, Xie H, Zeng Y, Shen Z, Fan Z, Liu Z, Zhang S. Serum chemokine CCL17/thymus activation and regulated chemokine is correlated with coronary artery diseases. Atherosclerosis. 2015;238:365-369. doi: 10.1016/j.atherosclerosis.2014.12.047.
52. Döring Y, Zernecke A. Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012;3:230. doi: 10.3389/fphys.2012.00230.
53. Habets KL, van Puijvelde GH, van Duivenvoorde LM, van Wanrooij EJ, de Vos P, Tervaert JW, van Berkel TJ, Toes RE, Kuiper J. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc Res. 2010;85:622-630. doi: 10.1093/cvr/cvp338.
54. Hermansson A, Johansson DK, Ketelhuth DF, Andersson J, Zhou X, Hansson GK. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation. 2011;123:1083-1091. doi: 10.1161/ CIRCULATIONAHA.110.973222.